CORONAVIRUS
Chiesi Group is closely monitoring the COVID-19 outbreak and is acting in order to make the health and wellbeing of patients and employees a priority. Dedicated teams across our network are taking measures to protect the continuous supply of our medicines in all countries and implemented strict guidelines to ensure the safety of all employees across the Chiesi Group in line with government policies and needs and following the WHO recommendations. We are committed to our focus on improving the quality of human life and put people at the center of our actions, to protect the health and wellbeing of our employees, patients and partners.

  • /
    NEWS
© 2025 Chiesi Canada Corp
3800 Steeles Ave. West
Suite 100E
Woodbridge, Ontario
L4L 4G9
FCAFR75

PHARMACOVIGILANCE

VEUILLEZ CLIQUEZ ICI POUR SIGNALER LES ÉVÉNEMENTS/RÉACTIONS INDÉSIRABLES LIÉS AU MÉDICAMENT


SUIVEZ-NOUS SUR